Common Contracts
5 similar null contracts by BioMed Realty Trust Inc
15,000,000 Shares of Common Stock (Par Value $0.01 Per Share) BioMed Realty Trust, Inc. (a Maryland Corporation) Underwriting AgreementBioMed Realty Trust Inc • September 29th, 2010 • Real estate investment trusts • New York
BioMed Realty Trust, Inc., a Maryland corporation (the “Company”), and BioMed Realty, L.P., a Maryland limited partnership (the “Operating Partnership” and together with the Company, the “Transaction Entities”), each confirms its agreement with Wells Fargo Securities, LLC (“Wells Fargo Securities”), Raymond James & Associates, Inc. (“Raymond James”), Morgan Stanley & Co. Incorporated (“Morgan Stanley”), UBS Securities LLC (“UBS”) and each of the other underwriters named in Schedule I hereto (the “Underwriters”) for whom Wells Fargo Securities, Raymond James, Morgan Stanley and UBS are acting as representatives (the “Representatives”) with respect to the issuance and sale by the Company and the purchase by the Underwriters, acting severally and not jointly, of 15,000,000 shares (the “Firm Securities”) of the Company’s common stock, par value $0.01 per share (the “Common Stock”), and with respect to the grant by the Company to the Underwriters, acting severally and not jointly, of an opt
11,500,000 Shares of Common Stock (Par Value $0.01 Per Share) BioMed Realty Trust, Inc. (a Maryland Corporation) Underwriting AgreementBioMed Realty Trust Inc • April 19th, 2010 • Real estate investment trusts • New York
BioMed Realty Trust, Inc., a Maryland corporation (the “Company”), and BioMed Realty, L.P., a Maryland limited partnership (the “Operating Partnership” and together with the Company, the “Transaction Entities”), each confirms its agreement with Raymond James & Associates, Inc. (“Raymond James”), Morgan Stanley & Co. Incorporated (“Morgan Stanley”), UBS Securities LLC (“UBS”), Wells Fargo Securities, LLC (“Wells”) and KeyBanc Capital Markets Inc. (“KeyBanc”) and each of the other underwriters named in Schedule I hereto (the “Underwriters”) for whom Raymond James, Morgan Stanley, UBS, Wells and KeyBanc are acting as representatives (the “Representatives”) with respect to the issuance and sale by the Company and the purchase by the Underwriters, acting severally and not jointly, of 11,500,000 shares (the “Firm Securities”) of the Company’s common stock, par value $0.01 per share (the “Common Stock”), and with respect to the grant by the Company to the Underwriters, acting severally and no
16,000,000 Shares of Common Stock (Par Value $0.01 Per Share) BioMed Realty Trust, Inc. (a Maryland Corporation) Underwriting AgreementBioMed Realty Trust Inc • May 18th, 2009 • Real estate investment trusts • Florida
BioMed Realty Trust, Inc., a Maryland corporation (the “Company”), and BioMed Realty, L.P., a Maryland limited partnership (the “Operating Partnership” and together with the Company, the “Transaction Entities”), each confirms its agreement with Raymond James & Associates, Inc. (“Raymond James”), KeyBanc Capital Markets Inc. (“KeyBanc”), Morgan Stanley & Co. Incorporated (“Morgan Stanley”), UBS Securities LLC (“UBS”), Wachovia Capital Markets, LLC (“Wachovia”) and Credit Suisse Securities (USA) LLC (“Credit Suisse”) and each of the other underwriters named in Schedule I hereto (the “Underwriters”) for whom Raymond James, KeyBanc, Morgan Stanley, UBS, Wachovia and Credit Suisse are acting as representatives (the “Representatives”) with respect to the issuance and sale by the Company and the purchase by the Underwriters, acting severally and not jointly, of 16,000,000 shares (the “Firm Securities”) of the Company’s common stock, par value $0.01 per share (the “Common Stock”), and with res
6,950,000 Shares of Common Stock (Par Value $0.01 Per Share) BioMed Realty Trust, Inc. (a Maryland Corporation) Underwriting AgreementBioMed Realty Trust Inc • August 21st, 2006 • Real estate investment trusts • Florida
BioMed Realty Trust, Inc., a Maryland corporation (the “Company”), and BioMed Realty, L.P., a Maryland limited partnership (the “Operating Partnership” and together with the Company, the “Transaction Entities”), each confirms its agreement with Raymond James & Associates, Inc. (“Raymond James”) and each of the other underwriters named in Schedule I hereto (the “Underwriters”) for whom Raymond James is acting as representative (the “Representative”) with respect to the issuance and sale by the Company and the purchase by the Underwriters, acting severally and not jointly, of 6,950,000 shares (the “Firm Securities”) of the Company’s common stock, par value $0.01 per share (the “Common Stock”), and with respect to the grant by the Company to the Underwriters, acting severally and not jointly, of an option to purchase an aggregate of not more than 1,042,500 additional shares of Common Stock (the “Optional Securities”), subject to the terms and conditions set forth below. The Firm Securitie
9,075,000 Shares of Common Stock (Par Value $0.01 Per Share) BioMed Realty Trust, Inc. (a Maryland Corporation) Underwriting AgreementBioMed Realty Trust Inc • May 16th, 2006 • Real estate investment trusts • Florida
BioMed Realty Trust, Inc., a Maryland corporation (the “Company”), and BioMed Realty, L.P., a Maryland limited partnership (the “Operating Partnership” and together with the Company, the “Transaction Entities”), each confirms its agreement with Raymond James & Associates, Inc. (“Raymond James”) and each of the other underwriters named in Schedule I hereto (the “Underwriters”) for whom Raymond James is acting as representative (the “Representative”) with respect to the issuance and sale by the Company and the purchase by the Underwriters, acting severally and not jointly, of 9,075,000 shares (the “Firm Securities”) of the Company’s common stock, par value $0.01 per share (the “Common Stock”), and with respect to the grant by the Company to the Underwriters, acting severally and not jointly, of an option to purchase an aggregate of not more than 1,361,250 additional shares of Common Stock (the “Optional Securities”), subject to the terms and conditions set forth below. The Firm Securitie
